Patient journey and resources mapping to implement a praziquantel mass drug administration program for children aged 5 years and below in resource-limited settings
Abstract Background The early childhood development of millions of children in some low- and medium-income countries may be compromised by schistosomiasis infections contracted at the age of 5 years and below. Currently, there are no standard guidelines for treating schistosomiasis in children that...
Main Authors: | Mhlengi Vella Ncube, Muhubiri Kabuyaya, Moses John Chimbari |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | Systematic Reviews |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13643-022-02087-z |
Similar Items
-
Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review
by: Muhubiri Kabuyaya, et al.
Published: (2018-07-01) -
A prospective risk assessment of the implementation of a schistosomiasis preventive mass drug administration for children aged five years and below in the uMkhanyakude district of KwaZulu-Natal
by: Mhlengi Vella Ncube, et al.
Published: (2019-10-01) -
The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of age
by: Emily L. Webb, et al.
Published: (2021-09-01) -
Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa
by: Muhubiri Kabuyaya, et al.
Published: (2017-04-01) -
Infection status and risk factors associated with urinary schistosomiasis among school-going children in the Ndumo area of uMkhanyakude District in KwaZulu-Natal, South Africa two years post-treatment
by: Muhubiri Kabuyaya, et al.
Published: (2018-06-01)